HRS4R
Vull donar
Firma
GEMMA VIÑAS-VILARÓ
Posició
Investigador/a Post-doctoral – R2
Investigadors/es Post-doctorals – R2

Projectes

Codi oficial: H2845SM6P Data inici: 01/01/2023 Data fi: 31/12/2024 Investigador/a principal: ARANTXA ERASO URIÉN Organisme finançador: AGENCIA DE GESTIO D'AJUTS UNIV. I RECER. Ajuda: 24,000 €

Publicacions

Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Font R, Marcos-Gragera R, Puigdemont M, Viñas G, Carulla M, Espinàs JA, Galceran J, Izquierdo Á, Borràs JM

Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2023, 20 dx.doi.org/10.3390/ijerph20010405
0

No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy: A Probabilistic Graphical Modeling Approach

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 dx.doi.org/10.3390/ijerph19063605
0

Using population-based data to evaluate the impact of adherence to endocrine therapy on survival in breast cancer through the web-application BreCanSurvPred

SCIENTIFIC REPORTS, 2022, 12, 8097-8097 dx.doi.org/10.1038/s41598-022-12228-y
0

COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13 dx.doi.org/10.1177/17588359211053416

Lopez-Bonet E, Buxó M, Cuyàs E, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Oliveras G, Meléndez C, Castillo L, Verdura S, Brunet J, Joven J, Garcia M, Saidani S, Martin-Castillo B, Menendez JA

Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer

Journal of Clinical Medicine, 2019, 8 dx.doi.org/10.3390/jcm8122180

Cuyàs E, Fernández-Arroyo S, Buxó M, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Verdura S, Brunet J, López-Bonet E, Garcia M, Saidani S, Joven J, Martin-Castillo B, Menendez JA

Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients

Aging-Us, 2019, 11, 2874-2888 dx.doi.org/10.18632/aging.101960

Cuyàs E, Buxó M, Ferri Iglesias MJ, Verdura S, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Joven J, Brunet J, López-Bonet E, Garcia M, Saidani S, Queralt Moles X, Martin-Castillo B, Menendez JA

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin

Frontiers in oncology, 2019, 9, 193-193 dx.doi.org/10.3389/fonc.2019.00193

Pietzke M, Arroyo SF, Sumpton D, Mackay GM, Martin-Castillo B, Camps J, Joven J, Menendez JA, Vazquez A, METTEN study group

Stratification of cancer and diabetes based on circulating levels of formate and glucose

CANCER & METABOLISM, 2019, 7, 3-3 dx.doi.org/10.1186/s40170-019-0195-x

Roca-Barceló A, Viñas G, Pla H, Carbó A, Comas R, Izquierdo Á, Pinheiro PS, Vilardell L, Solans M, Marcos-Gragera R

Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994-2013)

CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21, 891-899 dx.doi.org/10.1007/s12094-018-1994-1
0

Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer

BREAST CANCER RESEARCH, 2019, 21, 79-79 dx.doi.org/10.1186/s13058-019-1160-x

Formulari de contacte

Coneix l’IDIBGI!

menu